Shan Yuan, M.D.

American Board of Pathology, Blood Banking/Transfusion Medicine
American Board of Pathology, Clinical Pathology
Unrestricted Medical License, State of California
United States Medical Licensing Examination
1996-2000, Doctor of Medicine, Duke University School of Medicine, Durham, NC
1992 –1996, Bachelor of Arts, Biology, Oberlin College, Oberlin, OH
2004 –2005, Fellow, Transfusion Medicine, Puget Sound Blood Center and University of Washington Medical Center, Seattle, WA
2000 –2004, Chief Resident, Laboratory Medicine (2003-2004), Resident, Anatomic Pathology and Laboratory Medicine, University of Washington Medical Center, Seattle, WA
2012 - present, Associate Clinical Professor, Department of Pathology, City of Hope, Duarte, CA
2007 - 2012, Associate Medical Director of Transfusion Medicine, Assistant Professor, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
2005 - 2007, Staff Physician, Transfusion Medicine, City of Hope, Duarte, CA
2010-2011, Faramarz Naeim Faculty Teaching Award for Clinical Pathology, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA
2004, Paul E. Strandjord Young Investigator Award, 39th Annual Meeting of the Academy of Clinical Physicians and Scientists
2003, Strandjord-Clayson Research Award, Department of Laboratory Medicine, University of Washington Medical Center
2003, Paul E. Strandjord Young Investigator Award, 38th Annual Meeting of the Academy of Clinical Physicians and Scientists
American Association of Blood Banks
California Blood Bank Society
American Society of Hematology
- Yuan S, Otrock ZK. Platelet Transfusion: An Update on Indications and Guidelines. Clin Lab Med. 2021 Dec;41(4):621-634.
- Zhuang L, Lauro D, Wang S, Yuan S. Addition of plerixafor in poorly mobilized allogeneic stem cell donors. J Clin Apher. 2022 Aug;37(4):388-394.
- Yuan S, Yang DY, Nakamura R, Zhuang LF, Al Malki MM, Karanes C, Wang S. RBC and platelet transfusion requirements in the first 30 and 100 days after allogeneic hematopoietic cell transplantation and transfusion independence. Transfusion 2020;60:2225-2242.
- Zhuang L, Boriboonnangkul P, Wang S, Yuan S. Third time’s a charm? Mobilization of autologous peripheral blood stem cells in patients with two previous failed mobilizations with plerixafor. Transfusion 2020;60:1253-1259
- Yuan S, Zhuang LF, Stinson S, Barton P, Noeller J, Garcia A, Wang S. Red cell clumping in stem cell collection bag. Transfusion
2020;60:673-674. - Yuan S, Yang DY, Nakamura R, Zhuang LF, Al Malki M, Wang S. RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation. Transfusion 2019; 59:3371-3385.
- Park G, Shayani S, Stiller T, Wang S, Yuan S. Dose-capping of plerixafor in patients weighing >100 kg at one vial led to successful mobilization outcomes and significant cost savings. Transfusion 2018; 58:323-329.
- Salhotra A, Yuan S, Tsai NC, Sanchez JF, Aldoss I, Ali H, Paris T, Spielberger R, Cao TM, Nademanee A, Forman ST, Chen R. Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure Despite Plerixafor Rescue. Biology of Blood and Marrow Transplantation 2017; 23:1264-1268.
- Yuan S, Wang S. How do we mobilize and collect autologous peripheral blood stem cells. Transfusion 2016; 57:13-23.
- Finck RH, Ziman A, Hoffman M, Phan-Tang M, Yuan S. Motivating factors and potential deterrents to blood donation in high school aged blood donors. Accepted for publication by Journal of Blood Transfusion 2016;2016:8624230. doi: 10.1155/2016/8624230. Epub 2016 May 15.
- Yuan S, Palmer JM, Tsai N, Dagis A, Nademanee A, Wang S. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor Hematol Oncol. 2017:35:281-287.
- Salhotra A, Yuan S, Tsai NC, Sanchez JF, Aldoss I, Ali H, Paris T, Spielberger R, Cao TM, Nademanee A, Forman ST, Chen R. Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure Despite Plerixafor Rescue. Biology of Blood and Marrow Transplantation 2017; 23:1264-1268.
- Yuan S, Chang S, Uyeno K, Almquist G, Wang S. Blood donation mobile applications: Are donors ready? Transfusion. 2016; 56:614-621.
- Yuan S, Palmer JM, Tsai N, Dagis A, Nademanee A, Wang S. Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor Hematol Oncol. 2016 Feb 29;2016 DOI: 10.1002/hon.2286. [Epub ahead of print]
- Finck RH, Ziman A, Hoffman M, Phan-Tang M, Yuan S. Motivating factors and potential deterrents to blood donation in high school aged blood donors. Accepted for publication by Journal of Blood Transfusion 2016;2016:8624230. DOI: 10.1155/2016/8624230. Epublished.
- Yuan S, Wang S. How do we mobilize and collect autologous peripheral blood stem cells. Transfusion 2016; 57:13-23.
- Yuan S, Nademanee A, Kaniewski M, Palmer J, Shayani S, Wang S. Efficacy of Just-in-Time Plerixafor Rescue for Hodgkin Lymphoma Patients with Poor Peripheral Blood Stem Cell Mobilization. Transfusion. 2014;54:2015-2021.
- Yuan S, Wang S, Salhotra A, Nademanee A. Plerixafor to the rescue: Boosting peripheral blood stem cell mobilization in patients previously treated with Hyper-CVAD chemotherapy. Leukemia and Lymphoma. 2014 Jul;55:1557-62
- Yuan S, Nademanee A, Krishnan A, Kogut N, Shayani S, Wang S. Second time the charm? Remobilization of peripheral blood stem cells in patients who had previously mobilized poorly despite using plerixafor as a salvage agent. Transfusion 2013;53: 3244-3250.
- Yuan S, Tsukahara E, De La Cruz K, Kelly R. How we provide transfusion support for pediatric patient on extracorporeal membrane oxygenation (ECMO). Transfusion 2013;53:1157-65.
- Yuan S, Hoffman M, Lu Q, Goldfinger D, Ziman A. Motivating factors and deterrents for blood donation among donors at a university campus-based collection center. Transfusion 2011;51:2435-44.
- Yuan S, Fang A, Davis R, Siplon CJ, Goldfinger D. Immunoglobulin M red blood cell alloantibodies are frequently adsorbed by rabbit erythrocyte stroma. Transfusion 2010;50:1139-43.
- Yuan S, Ziman A, Smeltzer B, Lu Q, Goldfinger, D. Moderate and severe adverse events associated with blood component donations by apheresis: incidences and risk factors. Transfusion 2010;50:478-86.
- Yuan S, Ziman A, Anthony MA, Tsukahara E, Hopkins C, Lu Q, Goldfinger D. How do we provide transfusion to trauma patients. Transfusion 2009;49:1045-9.
- Yuan S, Davis R, Lu Q, Goldfinger D, Ziman A. Low risk of alloimunization to the Rh(D) antigen in Rh(D-) orthotopic liver transplant recipients receiving Rh(D+) RBCs perioperatively. Transfusion. 2008;48:2653-5.
- Yuan S, Goldfinger D. Editorial: A new assay for anti-IgA: is this what we have been waiting for? Transfusion 2008;48:2048-50.